Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics. They focus on creating drugs that silence disease-causing genes, targeting conditions such as liver disease, cancer, and cardiovascular diseases. The company generates revenue through partnerships, licensing agreements, and the commercialization of its proprietary therapies. Founded in 2003, Arrowhead has a history of innovation in genetic medicine and has established collaborations with major pharmaceutical companies to advance its pipeline of RNAi-based treatments.

Recent Posts by Arrowhead Pharmaceuticals

1-20 of 88